Mihir Shah - May 21, 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role: Chief Financial Officer
Signature: By: Mark Hueppelsheuser, Attorney-in-Fact For: Mihir Shah
Stock symbol: TOI
Transactions as of: May 21, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/23/2024, 06:33 PM
Previous filing: Dec 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Common Stock	Award	$0	+151K	+46.82%	$0.00	475K	May 21, 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TOI	Non-Qualified Stock Option (right to buy)	Award	$0	+379K		$0.00	379K	May 21, 2024	Common Stock	379K	$2.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
F2	Amount includes a reduction of 4,650 shares from the prior filing, as it corrects an inadvertent overstatement of holdings due to clerical error.
F3	The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.